LAS VEGAS — In this video from Clinical Trials at the Summit, Ashkan M. Abbey, MD, FASRS, FAAO, of Texas Retina Associates, discusses multiple pathways to treat wet age-related macular degeneration.
“I think we need to start looking at our treatments for wet AMD in more of a multimodal fashion, attacking it through multiple pathways in order to get both better efficacy and also durability, hopefully, for our patients in the future,” Abbey told Healio.